Pfizer’s (PFE) Overweight Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Pfizer (NYSE:PFE – Free Report) in a report published on Monday, Benzinga reports. They currently have a $45.00 price target on the biopharmaceutical company’s stock. A number of other brokerages have also recently commented on PFE. UBS Group increased their price target on Pfizer from $30.00 […]
More Stories
Major Automakers Side With Trump in Legal Battle Over Eased Fuel Economy Standards
By Kimberly Hayek A major auto industry group has thrown its support behind the Trump administration in a lawsuit brought...
Oil Prices Rise After Reports of Explosions on Iran’s Qeshm Island
By Evgenia Filimianova Oil prices climbed by more than 1.5 percent early on Nov. 3 after reports of explosions on...
Spanish Police Launch Investigation Into Death of Soccer Player After On-field Incident
By Elma Aksalic Spanish authorities have launched an investigation following the death of professional soccer player Jesús de Miguel, who...
Trump Designates Anti-Communism Week in Election Day Proclamation
By Travis Gillmore WASHINGTON—President Donald Trump declared Nov. 1 through Nov. 7 as Anti-Communism Week with a presidential action signed...
Trump Declares Outer Space Open for All Humans to Explore
By Jill McLaughlin President Donald Trump signed a proclamation Nov. 3 declaring the solar system and outer space to be...
2026 Midterms: 5 Takeaways
By Lawrence Wilson, Jeremy Lott and Jackson Richman Democrats won a sweeping victory on Nov. 3, taking control of both...